Fingerprint
Dive into the research topics of 'Phase I/II study of galiximab, an anti-CD80 antibody, for relapsed or refractory follicular lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Myron S. Czuczman, Aron Thall, Thomas E. Witzig, Julie M. Vose, Anas Younes, Christos Emmanouilides, Thomas P. Miller, Joseph O. Moore, John P. Leonard, Leo I. Gordon, John Sweetenham, Baha Alkuzweny, Deborah M. Finucane, Bryan R. Leigh
Research output: Contribution to journal › Article › peer-review